Treatment of Adult Allergic Asthma Patients with MEMP1972A

Update Il y a 4 ans
Reference: EUCTR2011-003997-10

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objectives of this study are to evaluate the efficacy and safety of MEMP1972A in adult patients with allergic asthma inadequately controlled despite high dose inhaled corticosteroids ( ICS) (≥ 400 μg/day total daily dose of fluticasone propionate [FP] or equivalent) and a second controller after 36 weeks of treatment.


Inclusion criteria

  • Allergic asthma